Renaissance Technologies's AVNS Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 78,500 shares of Avanos Medical, Inc. (AVNS) worth $907,460, representing 0.00% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in AVNS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 79,900 shares. Largest reduction occurred in Q1 2022, reducing 120,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +140,700 | New Buy | 140,700 | $68.50 |
| Q4 2018 | -140,700 | Sold Out | 140,700 | $0.00 |
| Q2 2020 | +72,800 | New Buy | 72,800 | $29.40 |
| Q3 2020 | -72,800 | Sold Out | 72,800 | $0.00 |
| Q2 2021 | +87,800 | New Buy | 87,800 | $36.37 |
| Q3 2021 | +44,500 | Add 50.68% | 132,300 | $31.20 |
| Q4 2021 | -132,300 | Sold Out | 132,300 | $0.00 |
| Q1 2022 | +11,800 | New Buy | 11,800 | $33.47 |
| Q2 2022 | -3,000 | Reduce 25.42% | 8,800 | $27.39 |
| Q3 2022 | -8,800 | Sold Out | 8,800 | $0.00 |
| Q4 2022 | +21,600 | New Buy | 21,600 | $0.03 |
| Q1 2023 | +10,900 | Add 50.46% | 32,500 | $0.03 |
| Q2 2023 | -14,300 | Reduce 44.00% | 18,200 | $0.03 |
| Q3 2023 | +41,668 | Add 228.95% | 59,868 | $20.23 |
| Q4 2023 | -59,868 | Sold Out | 59,868 | $0.00 |
| Q1 2025 | +16,900 | New Buy | 16,900 | $14.33 |
| Q2 2025 | +79,900 | Add 472.78% | 96,800 | $12.24 |
| Q3 2025 | -18,300 | Reduce 18.90% | 78,500 | $11.56 |
Renaissance Technologies's Avanos Medical Investment FAQs
Renaissance Technologies first purchased Avanos Medical, Inc. (AVNS) in Q3 2018, acquiring 140,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Avanos Medical, Inc. (AVNS) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Avanos Medical, Inc. (AVNS) was in Q3 2018, adding 140,700 shares worth $9.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 78,500 shares of Avanos Medical, Inc. (AVNS), valued at approximately $907,460. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.00% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Avanos Medical, Inc. (AVNS) was 140,700 shares, as reported at the end of Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.